@supports((display: -ms-grid) or (display: grid)) { :root { /* header measurements */ --header-height-on-desktop: 10rem; --header-height-on-mobile: 10rem; --header-h1-font-size: -webkit-calc(2rem + (2.5 - 2) * ((100vw - 18.750rem) / (60 - 18.750))); --header-h1-font-size: -moz-calc(2rem + (2.5 - 2) * ((100vw - 18.750rem) / (60 - 18.750))); --header-h1-font-size: calc(2rem + (2.5 - 2) * ((100vw - 18.750rem) / (60 - 18.750))); } #header { background: none; } #header::before { content: " "; position: absolute; width: 100%; height: 100%; left: 0; top: 0.75rem; background-image: var(--logo-image); background-repeat: no-repeat; background-position: center -3.5rem; -webkit-background-size: auto 8rem; -moz-background-size: auto 8rem; -o-background-size: auto 8rem; background-size: auto 8rem; background-position: center top; opacity: 0.45; pointer-events: none; } #header h1, #header h1 a, #header h1 a::before { position: absolute; top: 0; left: 0; margin: 0; padding: 0; width: 100%; height: 100%; display: -webkit-box; display: -webkit-flex; display: -moz-box; display: -ms-flexbox; display: flex; -webkit-box-align: center; -webkit-align-items: center; -moz-box-align: center; -ms-flex-align: center; align-items: center; -webkit-box-pack: center; -webkit-justify-content: center; -moz-box-pack: center; -ms-flex-pack: center; justify-content: center; max-height: inherit; z-index: 0; } #header>h1>a>span { width: 100%; height: 100%; top: 0; left: 0; max-width: inherit; } #header h1 { height: -webkit-calc(100% - 2.25rem); height: -moz-calc(100% - 2.25rem); height: calc(100% - 2.25rem); } #header h1 a::before, #header h1 a { text-align: center; line-height: 0.8; } #header h2, #header h2 span, #header h2 span::before { position: absolute; left: 0; top: 0.15em; margin-left: 0; padding: 0; width: 100%; display: -webkit-box; display: -webkit-flex; display: -moz-box; display: -ms-flexbox; display: flex; -webkit-box-align: end; -webkit-align-items: flex-end; -moz-box-align: end; -ms-flex-align: end; align-items: flex-end; -webkit-box-pack: center; -webkit-justify-content: center; -moz-box-pack: center; -ms-flex-pack: center; justify-content: center; max-height: inherit; z-index: 0; text-transform: uppercase; pointer-events: none; } #login-status { min-height: -webkit-calc(var(--base-font-size) * 1.5); min-height: -moz-calc(var(--base-font-size) * 1.5); min-height: calc(var(--base-font-size) * 1.5); -webkit-border-radius: .0625rem; -moz-border-radius: .0625rem; border-radius: .0625rem; -webkit-border-radius: var(--border-radius-width); -moz-border-radius: var(--border-radius-width); border-radius: var(--border-radius-width); color: rgb(var(--pale-gray-monochrome)); background-color: rgba(0, 0, 0, 0); -webkit-box-sizing: border-box; -moz-box-sizing: border-box; box-sizing: border-box; -webkit-box-flex: 1; -webkit-flex-grow: 1; -moz-box-flex: 1; -ms-flex-positive: 1; flex-grow: 1; left: 3%; right: initial; } #login-status .printuser { --wght: 900; position: relative; top: 0; left: 0; color: rgb(var(--swatch-menutxt-light-color)); -webkit-box-shadow: none; -moz-box-shadow: none; box-shadow: none; padding: 0.25rem; margin: 0; font-weight: 900; } #login-status #my-account { --wght: 300; color: rgb(var(--pale-gray-monochrome)); font-weight: 300; } #login-status #account-topbutton { border: initial; padding: 0.5em 0.5em 0.5em 0.25em; position: relative; height: 100%; top: 0; left: 0; margin: 0; font-size: 1em; } #account-options { width: auto; padding: 0.5em; border-color: rgba(var(--bright-accent)); background: var(--gradient-header); color: rgb(var(--swatch-text-light)); } #account-options ul li a { color: rgb(var(--swatch-text-light)); } #account-options li a:hover { color: rgb(var(--swatch-text-light)); text-decoration: underline; } @media only screen and (min-width: 769px) { #search-top-box { right: 3%; top: 0.5rem; } #search-top-box-form>input, #search-top-box-form>input:hover, #search-top-box-form>input:focus { background: rgb(var(--black-monochrome)); } #search-top-box-form>input { -webkit-box-shadow: 0 0 0 0.125rem rgb(var(--swatch-menubg-dark-color)); -moz-box-shadow: 0 0 0 0.125rem rgb(var(--swatch-menubg-dark-color)); box-shadow: 0 0 0 0.125rem rgb(var(--swatch-menubg-dark-color)); } #search-top-box-form>input:hover, #search-top-box-form>input:focus { -webkit-box-shadow: 0 0 0 0.125rem rgb(var(--swatch-menubg-medium-dark-color)); -moz-box-shadow: 0 0 0 0.125rem rgb(var(--swatch-menubg-medium-dark-color)); box-shadow: 0 0 0 0.125rem rgb(var(--swatch-menubg-medium-dark-color)); } #search-top-box-form input[type="submit"], #search-top-box-form input[type="submit"]:focus, #search-top-box-form input[type="submit"]:hover { border: none; border-left: 0.0625rem solid rgb(var(--swatch-primary-darkest)); -webkit-box-shadow: 0 0 0 0.125rem rgb(var(--swatch-menubg-dark-color)); -moz-box-shadow: 0 0 0 0.125rem rgb(var(--swatch-menubg-dark-color)); box-shadow: 0 0 0 0.125rem rgb(var(--swatch-menubg-dark-color)); } #search-top-box-form input[type="submit"] { background: rgb(var(--swatch-primary-darkest)); color: rgb(var(--swatch-menutxt-light-color)); } #search-top-box-form input[type="submit"]:focus, #search-top-box-form input[type="submit"]:hover { background: rgb(var(--swatch-primary)); -webkit-box-shadow: 0 0 0 0.125rem rgb(var(--swatch-menubg-medium-dark-color)); -moz-box-shadow: 0 0 0 0.125rem rgb(var(--swatch-menubg-medium-dark-color)); box-shadow: 0 0 0 0.125rem rgb(var(--swatch-menubg-medium-dark-color)); } } #page-title { text-align: center; } @media only screen and (max-width:768px) { :root { --header-h1-font-size: -webkit-calc(2rem + (2.5 - 2) * ((100vw - 18.750rem) / (60 - 18.750))); --header-h1-font-size: -moz-calc(2rem + (2.5 - 2) * ((100vw - 18.750rem) / (60 - 18.750))); --header-h1-font-size: calc(2rem + (2.5 - 2) * ((100vw - 18.750rem) / (60 - 18.750))); } #header h1, #header h1 a, #header h1 a::before { top: 0.25rem; } #header h2, #header h2 a, #header h2 a::before { top: 0; } #header h2 span { margin-top: -webkit-calc(var(--header-height-on-mobile)/2 + var(--header-h1-font-size)/2 + .25rem); margin-top: -moz-calc(var(--header-height-on-mobile)/2 + var(--header-h1-font-size)/2 + .25rem); margin-top: calc(var(--header-height-on-mobile)/2 + var(--header-h1-font-size)/2 - .25rem); } }
|
|
PROLOGUE: The Hearing (working title)
Grasping the handle on the door to her office, she jerks it open and readily enters.
Between overseeing the administering of several amnestics on civilians in Atlanta and the emergency veil-related meetings that have populated her week, to say that Althea was tired would be an unequivocal understatement.
Althea removes her coat and places her cold cup of coffee down on her desk. She promptly powers on her monitor. She runs a tired hand through her hair as she settled down in her chair. She opens up the SCiPNET secure portal and promptly enters her credentials.
Access SCiPNET Email? Eleven (11) new messages!
Althea sighs, glossing over the emails sent to her. All of them are either reminders about meetings, requests to review documentation, or questions about current assignments. She will have to make a note to respond to a few of these later. She was about to close the window before noticing another email slide into her inbox. She quickly opens it up.
From: Sec. Joseph Esposito (tni.pcs.ds|otisopsej#tni.pcs.ds|otisopsej)
To: Dr. Althea Z Llarena (tni.pcs.nma|aneralla#tni.pcs.nma|aneralla)
Subject: Concerning Unit Proposal
Dear Dr. Llarena,
Writing to notify you that the Office of Scientific Department Leadership has reviewed your proposal regarding the formation of a new research unit and has decided to approve your proposal for consideration.
A provisional committee on your proposal (now Agreement SD-023-299-1725) is currently in the process of selection, and a hearing will be held on Thursday at 3:30 PM EST and will likely last for several hours. Please clear your schedule to accommodate this timeframe.
Good luck,
Joseph Esposito
Office of Scientific Department Leadership
Secure, Contain, Protect
Concerning Unit Request
Date: 7/18/2021
From: Sec. Joseph Esposito (Office of the Scientific Dept. Leadership)
CC: Scientific Department Command [ALL], Amnestics Division Leadership [ALL]
To: Dr. Althea Z Llarena (IRIS1 Officer)
Dear Dr. Llarena,
First off, congratulations on your recent promotion. Your work in the Identity Reconstruction Inquiries Service along with your last seven years with the Foundation have clearly shown your dedication to our organization.
According to the Amnestics Division's records, you've requested to form an independent research team four times in the past five years. Each time your request had been denied.
After speaking with my colleagues in the Scientific Department's leadership, we've come to the decision to finally approve your request to start the official process of forming and leading your own research team.
Attached to this memo are all the necessary clearances and documents you and anyone else you will be bringing onto this team will need to proceed with the legitimization of your unit.
Thank you for your service to the Foundation.
Sincerely,
Joseph Esposito
Secretary of the Office of the Scientific Department Leadership
RE: Concerning Unit Request
Date: 7/18/2021
From: Dr. Althea Z Llarena (IRIS Officer)
To: Sec. Joseph Esposito (Scientific Department)
Oh my god.
"ARMOR" Formation & Conscription Agreement
Serial Request #: SD-023-299-1725
Approved by: Office of the Scientific Department Leadership
Approval date: 7/17/2021
Name of Unit: Amnestics Research & Memory Observation Reserve
Parent Division: Amnestics Division
Project Lead: Dr. Althea Z Llarena
Assisting Project Leads: Dr. Kevin Lau, Dr. Vicky Comescu
Description: The Amnestics Research & Memory Observation Reserve is a specialized research team dedicated to the advancement of Foundation amnestic compounds and overseeing the application of experimental amnestics that can be used to reverse and/or cure the effects of anomalous memetic objects while also studying memory-affecting anomalies and their possible applications in amnestics and amnestic testing.
| Provisional Committee on Agreement SD-023-299-1725 "ARMOR" |
|---|
| Dr. Althea Z Llarena (Project Lead) |
| Dr. Kevin Lau (Office of Amnestics Div. Leadership) |
| Dir. Sarah Metty (Site-02 Command) |
| Dr. Vicky Comescu (Senior Amnesticologist) |
| Sec. Joseph Esposito (Office of the Scientific Dept. Leadership) |
| Officer Ishleen Bijarniya (Ethics Committee Representative) |
| Dr. Ashanti Watts (Senior Psychologist) |
| Dr. Ross Padilla (Senior Memetologist) |
| Dr. Regina Turner (Senior Neurologist) |
| Provisional Committee's Minor Advisory Cabinet |
| Dr. Simon Glass (Head of Psychology) |
| Dr. Juliet Romati (Senior Researcher) |
| Dr. Andy Li (Senior Researcher) |
| Dr. Jacquelyn Smith (Junior Researcher) |
| Officer Maria Roy (Administrative Department) |
| Dir. Pedro Bush (Director of IRIS) |
Committee on Agreement SD-023-299-1725 "ARMOR"
Date: 7/18/2021
From: Dr. Kevin Lau (Office of Amnestics Div. Leadership)
To: Committee on Agreement SD-023-299-1725 [ALL]
Emailing to notify the committee that SCiPNET Technicians have set up the messaging group, so we are ready to begin the discussion on Agreement SD-023-299-1725.
We'll move through the discussion by reviewing each section of the Agreement, the Project Lead and assistant Leads may edit any part of the document while the committee and the advisory cabinet give their input.
Date: 7/18/2021
From: Dir. Sarah Metty (Site-02 Command)
To: Committee on Agreement SD-023-299-1725 [ALL]
Greetings, everyone.
To cut to the chase, I expressed my skepticism with the Scientific Department about the necessity of this research unit. As I'm still not 100% convinced there's a need for a specialized unit for amnestics research, we already have the Amnestics Division's general research units. Though I am open to being convinced otherwise.
Date: 7/18/2021
From: Dr. Regina Turner (Senior Neurologist)
To: Committee on Agreement SD-023-299-1725 [ALL]
A few issues I've noticed with the Amnestics Division is that the division as a whole seems to be more concerned with being the authority on administering amnestics and coordinating the distribution of said amnestics. Around 80% of breakthroughs in amnestic research are usually by independent teams studying anomalous substances. (Aztak2, for example)
I am less concerned about redundancy or necessity, but I am concerned about the name outlined on Project Lead. Dr. Llarena has been instrumental in a number of discoveries in mind-affecting SCPs and her work in IRIS requires no explanation. But her reputation for her… pervasive behaviors is what concern me the most about this agreement.
Date: 7/18/2021
From: Dr. Althea Z Llarena (IRIS Officer)
To: Committee on Agreement SD-023-299-1725 [ALL]
Always a pleasure Regina. I assure you my alledged personal biases and behaviors will not affect the efficacy of my proposed unit, for I am fully capable of leading this research unit as I've helped lead many others prior to this one.
But building on what Regina said, the Amnestics Division is undeniably more focused on the application of amnestics and their distribution. The general research units for the Amnestics Division lack the resources, clearances, and personnel required to push the boundaries of amnesticology, which is why we need a unit like this one.
Date: 7/18/2021
From: Dr. Ashanti Watts (Senior Psychologist)
To: Committee on Agreement SD-023-299-1725 [ALL]
Prior to my induction onto this committee, I went through Dr. Llarena's psych evaluation. I see no reason why she wouldn't be the perfect choice to lead this research team. I think it's unfair to allow such unfounded claims to cloud your judgment.
Date: 7/18/2021
From: Sec. Joseph Esposito (Office of the Scientific Dept. Leadership)
To: Committee on Agreement SD-023-299-1725 [ALL]
If there aren't any requested changes, we should move forward through the agreement.
Available Headquarter Candidates
Site-142
Site-77
Type: Administrative
Description: Foundation installation located in [DATA REDACTED], Washington3.
Site-77 is a building outfitted with command facility requirements along with 140 offices. Site-77 was originally constructed as an auxiliary command post but is presently left unused.
Status: Unoccupied
Contained SCPs: N/A
Comments:
None.
Site-142
Site-142
Type: Containment
Description: Foundation installation located in [DATA REDACTED], Egypt.
Site-142 is a subterranean complex outfitted with standard facility requirements along with 6 laboratory rooms, 15 offices, 40 morphic containment modules, and twelve object containment storage rooms.
Status: Partially Occupied4
Contained SCPs: Full list can be accessed here.
Comments:
None.
Site-156
Site-156 [SELECTED]
Type: Research & Development
Description: Foundation installation located in [DATA REDACTED], Malaysia.
Site-156 is a building outfitted with standard facility requirements along with 15 laboratory rooms, 20 offices, 14 morphic containment modules, and two object containment storage rooms.
Status: Unoccupied
Contained SCPs: N/A
Comments:
This is literally perfect. I'm picking this one. All the others suck - Dr. Llarena
Requested Items
Item(s): 75 50mL canisters of Y-909
Status: ACCEPTED
Comments:
Dir. Eckelkamp has agreed to provide access to all information regarding Y-909 with ARMOR.
- INWBKL Site-151 Command
Item(s): 4 containers of AMN-868
Status: ACCEPTED
Comments:
None






Per 



